Humana Inc. (HUM) Executive Summary Humana Inc. is a large health insurance and managed-care company focused on Medicare Advantage and related services, with a steadily growing revenue base but evolving profitability and cash-flow dynamics. The company’s top line has shown consistent per-share expansion: revenue per share rose to $1,073.15 at year-end 2025 and posted 1‑year revenue-per-share growt
Humana Inc. is a large health insurance and managed-care company focused on Medicare Advantage and related services, with a steadily growing revenue base but evolving profitability and cash-flow dynamics.
The company’s top line has shown consistent per-share expansion: revenue per share rose to $1,073.15 at year-end 2025 and posted 1‑year revenue-per-share growth of about 10.1% (with a 5‑year revenue-per-share CAGR of 10.94%), supporting consolidated revenue near $32.5B in the most recent quarter (see Revenue & Net Income and EPS Diluted & Revenue per Share). The balance sheet appears conservative by leverage measures: reported net debt metrics indicate effectively zero net debt relative to owner earnings, debt-to-equity is 0.7005, and the current ratio is about 2.00, leaving liquidity headroom for operations and strategic moves. Net income has been relatively predictable on a trailing basis (stability metric >3) with a latest TTM net income near $1.19B, which has helped support book‑value per share compounding (~5.54% 5‑year CAGR).
Profitability margins have eroded sharply: the most recent gross margin was 2.1%, operating margin was -9.8%, and net margin was about 0.9% (see Profit Margin Trends). EPS growth is negative on a year‑over‑year basis (about -1.57% in the latest signal and -1.6% reported for the latest twelve months), and diluted EPS moved from $14.15 in early 2025 down to $9.83 at year‑end, while quarterly net income swung to a Q4 2025 loss of -$796M. Cash‑flow quality is a concern: operating cash flow TTM was $921.0M versus TTM net income of $1.19B, implying operating cash generation at roughly 77.5% of reported earnings (see Earnings Quality Analysis and Revenue & Net Income).
The foundation of business quality and long-term value creation
HUMANA INC’s revenue shows a multi-year upward trend, roughly doubling from about $14.2B in late 2018 to the low-$30B range in 2025. Revenue has increased year-over-year each year from 2018 through 2025, with step-ups evident around 2021–2022 and continued growth into 2023–2024; 2025 quarterly revenue has been stable in the ~$32B range, rising slightly through Q3 then dipping marginally in Q4.
Net income displays pronounced seasonality and more volatility than revenue. Historically, HUMANA INC recorded stronger mid-year and Q1 profits (peaking at $1.83B in 2020-06 and $1.24B in several Q1s), while Q4 results have been losses that have deepened in recent years (Q4 2022: -$15.0M; Q4 2023: -$541.0M; Q4 2024: -$693.0M; Q4 2025: -$796.0M).
Through 2025, net income declined sequentially from $1.24B (2025-03) to $545.0M (2025-06) to $195.0M (2025-09) to a loss of -$796.0M (2025-12). The most recent quarterly revenue was $32.52B and the most recent quarterly net income (loss) was -$796.0M.
Why Growth Matters
Consistent revenue and earnings growth are the lifeblood of successful long-term investments. Companies that can grow their top line (revenue) and bottom line (net income) over many years demonstrate they have products or services customers value and are willing to pay for repeatedly.
Revenue Growth shows whether the company is expanding its market reach, gaining market share, or successfully launching new products.Net Income Growth demonstrates the company can convert that revenue into actual profits while managing costs effectively.
Look for steady, sustainable growth rather than erratic spikes. The best businesses compound earnings year after year, creating tremendous value for shareholders over time. Companies that can grow earnings faster than revenue are improving their profitability—a sign of operational excellence and competitive strength.
Year-over-year growth rates for revenue and earnings per share
Reading the Growth Rate Chart
This chart converts the absolute per-share figures into year-over-year percentage changes, making it easy to see whether growth is accelerating, decelerating, or reverting to trend — regardless of the company's absolute size.
Revenue per Share Growth (1-year, split-adjusted) measures how quickly the top line is expanding on a per-share basis. Sustained positive growth signals that the company continues to win customers and grow its addressable market.EPS Diluted Growth (1-year, split-adjusted) measures how quickly earnings are compounding for each shareholder. When EPS growth consistently outpaces revenue growth, operating leverage and margin expansion are at work.
Look for consistency, not just magnitude. A company that reliably grows EPS 10–15% per year is far more valuable than one that alternates between 50% spikes and deep contractions. Negative EPS growth during a period of positive revenue growth is a red flag — costs are rising faster than sales. Quarters where both lines converge near zero or go negative deserve close scrutiny.
How revenue converts to net income for the most recent annual period
Period Information
Report Type: Annual (10-K)
Period: Jan 2025 to Dec 2025
Revenue composition by disclosure category for the latest period
Revenue is derived from multiple sources within the company's diverse portfolio, including government health programs, insurance products, and pharmacy services.
The customer base spans various government programs, employer groups, military personnel, and retail consumers, reflecting the company's broad service reach.
Operations span nationwide and are concentrated in specific states, with extensive coverage across Medicare, Medicaid, and primary care services.
Distribution occurs through multiple channels, including direct, digital, and partner networks, enabling broad market access.
Revenue sources are characterized by contract-based, ongoing relationships, and some services generate recurring revenue while others are transactional.
The company's revenue heavily depends on government contracts, regulatory approvals, provider networks, and third-party relationships, which pose potential risks if disrupted.
Analyzing long-term margin stability and competitive positioning
HUMANA INC's net profit margin shows a long-term decline from the mid-single-digit range—around 3–5% in 2017–2021 and peaks near 4–5% in 2019–2020—to much lower levels in recent quarters, slipping from roughly 1.4–1.5% through early-to-mid 2025 to 0.9% in the most recent quarter. Prior periodic peaks (for example, 3.4%–3.5% in 2022–2023) have not been sustained into 2024–2025 based on the available trailing twelve-month figures.
Gross and operating margins exhibit large swings across the record. Gross margin was extremely high—near or at ~100%—through late 2023 and much of 2024–mid 2025 (100.0% on 2024-12-31, 96.7% on 2025-03-31, 90.8% on 2025-06-30)—before a pronounced drop to 2.1% in the quarter ending 2025-12-31; operating margin showed a similar pattern with very high positive readings in 2024–mid 2025 (88.4% on 2024-12-31, 85.1% on 2025-03-31, 79.1% on 2025-06-30) followed by a fall to -9.8% in the latest quarter. The most recent gross margin was 2.1%, operating margin -9.8%, and net profit margin 0.9%.
Understanding Profit Margins
Between Jan 2025 and Dec 2025, Humana Inc converts every dollar of revenue through the following stages:
Sustainable competitive advantages reveal themselves through consistently superior profit margins over extended periods. Companies with durable economic moats maintain pricing power and operational efficiency that competitors struggle to match.
A sign of durable competitive advantage is earning sustained higher margins than competitors.Look for margins that remain stable or improve over time, especially during economic downturns. Declining margins may signal increasing competition, pricing pressure, or deteriorating business fundamentals.
Comparing reported earnings to actual cash generation
HUMANA INC's trailing twelve‑month operating cash flow and net income have been volatile since mid‑2023. Operating cash flow peaked at $13.19B on 2023‑06‑30 and then fell sharply into negative territory across early and mid‑2024 (−$2.28B on 2024‑03‑31, −$4.25B on 2024‑06‑30, −$3.64B on 2024‑09‑30) while net income remained positive and more stable in the roughly $1.2B–$2.0B range. Operating cash flow recovered to positive TTM values by 2024‑12‑31 ($2.97B) and stayed above net income through much of 2025 before declining again in the most recent quarters.
Over the most recent four quarters operating cash flow declined from $2.93B (2025‑06‑30) to $921.0M (2025‑12‑31), while TTM net income moved from $1.58B to $1.19B over the same span, leaving net income higher than operating cash flow in the latest period. The latest TTM operating cash flow was $921.0M and the latest TTM net income was $1.19B.
The Earnings vs. Cash Flow Gap
Reported earnings (Net Income) doesn't always reflect actual cash generation. Companies use accrual accounting, which recognizes revenue when earned and expenses when incurred—not when cash actually changes hands. This creates timing differences and opportunities for accounting discretion that can mask underlying business health.
Net Income (the "earnings" number) can be influenced by non-cash items like depreciation, stock-based compensation, and changes in accounting estimates.Operating Cash Flow, however, shows the actual cash the business generates from its core operations—a harder number to manipulate.
What to Look For
Key Insight: Companies with durable competitive advantages typically show operating cash flow that meets or exceeds net income over time, demonstrating they convert accounting profits into actual cash that can be returned to shareholders or reinvested in the business.
Measuring management's efficiency at generating profits from shareholder capital
HUMANA INC's trailing twelve-month return on equity shows a clear long-term decline from the elevated levels seen in 2020–2021. ROE peaked at 26.2% for the quarter ending and remained mostly in the high teens to mid-20s through 2022 and early 2023 (20.3% on ; 20.1% on ), before falling into the mid-to-high teens and then into single digits thereafter.
Since late 2023, the metric has moved steadily lower with occasional modest rebounds:
The most recent quarterly ROE was 6.7%.
The Gold Standard of Profitability
Return on Equity (ROE) is a powerful measure of how effectively a company's management is using the money shareholders have invested. Calculated by dividing Net Income by Shareholders' Equity, it reveals how much profit is generated for every dollar of equity capital.
A consistently high ROE (typically above 15-20%) is often the signature of a "quality" business with a durable competitive advantage. It indicates that the company can generate high returns on its own capital, which it can then reinvest at these high rates to compound value over time.
What to Look For:
How the company generates and deploys its cash
Across 2024–2025 HUMANA INC's trailing twelve-month operating cash flow has moved from a prior trough (negative in mid-2024) to a multi-quarter positive run, peaking near $2.9B in late 2024 and mid-2025 before declining through 2025 to $921.0M at the 2025 year end.
Investing cash flow showed a clear inflection during 2025: it was a negative outflow around -$2.95B at 2024-12-31 and became progressively less negative through early 2025, turning positive by 2025-09-30 and rising to $2.27B by 2025-12-31.
Financing cash flow has been negative across recent quarters with larger outflows around mid-2025 (-$3.5B) and moderating to a smaller cash outflow by year end.
Note: Most recently, operating cash generation remains positive but reduced from earlier 2025 levels, investing cashflow is net positive, and financing cashflow shows an overall outflow that eased in the latest quarter.
Understanding Company Strategy
Capital allocation refers to how management decides to spend and invest the company's cash. Analyzing the three primary categories of cash flow reveals a company's true operational strategy:
What to look for: Is the company bootstrapping (funding growth solely from operating cash)? Are they borrowing to fund aggressive expansion or dividends? Or are they capital raising by issuing new shares, potentially diluting your ownership? A healthy, mature company typically generates strong operating cash, moderately invests in growth, and returns the surplus to shareholders through financing activities.
Net assets attributable to each share — the accounting floor of intrinsic value
Why Book Value per Share Matters
Book value per share is the net worth of the company — total assets minus total liabilities — divided by shares outstanding (split-adjusted). It represents the theoretical liquidation value per share if every asset were sold and every liability repaid at balance-sheet carrying values. It is the accounting foundation upon which much of equity valuation is built.
A steadily rising book value per share is one of the most reliable signals of compounding wealth creation. It means the company is retaining earnings and building net worth faster than it is returning capital or eroding it. Warren Buffett famously tracked Berkshire Hathaway's book value per share for decades as his primary measure of intrinsic value growth.
Context is essential. Asset-heavy businesses (banks, manufacturers, utilities) should be judged by book value more directly than asset-light businesses (software, consumer brands), where intangible assets like intellectual property and customer loyalty may far exceed their balance-sheet carrying values. A company trading at a large premium to book value is not necessarily overvalued — it may simply possess competitive advantages that accounting rules do not capture. Conversely, a declining book value per share — especially over multiple years — is a serious warning sign of capital destruction.
How much of the company is financed by debt versus shareholders' equity
Reading the Debt-to-Equity Ratio
The debt-to-equity (D/E) ratio compares total financial debt to shareholders' equity. A ratio of 1.0 means the company has borrowed one dollar for every dollar of equity; a ratio of 2.0 means it has borrowed twice as much as it owns. Financial leverage amplifies both returns and risk: in good times, debt turbocharges equity returns; in bad times, it accelerates losses and can threaten solvency.
Trends matter more than a single number. A rising D/E ratio can mean the company is taking on debt to fund growth — potentially value-creating if returns exceed the cost of capital. But it can also mean equity is being eroded through losses or that the business is borrowing simply to sustain operations. A falling D/E ratio generally reflects strengthening financial health: earnings are being retained, debt maturities are being paid down, or both.
Industry norms vary enormously. Capital-intensive sectors (utilities, real estate, financials) routinely carry high D/E ratios that would be alarming in, say, a technology company. Always compare against sector peers. As a rough rule of thumb, a D/E above 2× in a cyclical business warrants careful scrutiny of interest coverage and refinancing risk.
Short-term liquidity — can the company cover its near-term obligations?
Liquidity: Can the Business Pay Its Bills?
The current ratio is calculated as current assets divided by current liabilities. A ratio of 1.5 means the company has $1.50 of short-term assets — cash, receivables, inventory — for every $1.00 of obligations due within the next twelve months. It is the most direct measure of near-term financial resilience: can the business meet its obligations without needing to raise new capital or sell long-term assets at a discount?
A ratio above 1.0 is generally healthy, meaning current assets exceed current liabilities. A ratio consistently above 2.0 may indicate the company is holding excess cash or inventory that could be deployed more productively. A ratio below 1.0 is a warning sign — the company is relying on future cash generation or external financing to cover its near-term obligations, which is manageable in normal conditions but dangerous during a downturn.
Trends and context matter.A declining current ratio isn't always alarming — highly efficient businesses (e.g., large retailers with reliable daily cash flows) often run leaner balance sheets intentionally. Conversely, a rapidly rising current ratio can signal slowing sales causing inventory to build, or customers taking longer to pay. Always compare the trend against industry peers and cross-reference with the cash flow statement to assess whether the business is genuinely liquid or just holding non-cash current assets.
How much the market is paying for each dollar of company earnings
Over the past year HUMANA INC's trailing twelve-month P/E has shown volatility: it was 25.4x at 2024-12-31, dropped to 18.7x on both 2025-03-31 and 2025-06-30, then rose to 24.3x at 2025-09-30 and to 26.0x at 2025-12-31. The most pronounced recent inflection was the decline in early 2025 followed by a rebound through the second half of 2025.
Looking further back, the P/E progressed from single-digit readings in 2010–2013 (roughly 6–10x) into the mid-teens and low‑twenties across 2014–2023, with a notable spike to 38.9x at 2016-12-31. The most recent Price-to-Earnings ratio for HUMANA INC was 26.0x.
What Is the PE Ratio?
The Price-to-Earnings (PE) ratio is one of the most widely used valuation metrics in investing. It divides the current stock price by the company's earnings per share (EPS), revealing how much investors are willing to pay for each dollar of earnings. A high PE can signal that the market expects strong future growth, while a low PE may suggest undervaluation—or reflect genuine concerns about the company's prospects.
Context matters:PE ratios vary significantly across industries. High-growth technology companies routinely trade at PE ratios above 30x or 40x, while mature, low-growth sectors like utilities or financials often trade closer to 10–15x. Always compare a company's PE to its own history and its industry peers, not just an absolute number.
What to Look For:
Key Insight:The PE ratio is a snapshot of market sentiment and expectations. Tracking it over time alongside earnings trends reveals whether the market's valuation has expanded or contracted—and whether that change is justified by fundamentals.